NCAM1 and cancer: Other investigators have previously reported that immune cells with this phenotype have cytolytic activity against cancer cells and that CD8+ cells co-expressing CD56 may be generated in vitro by culturing PBMCs in media containing the powerful cytokine IL-2.32